David A. Siegel Sarepta Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 128,034 shares of SRPT stock, worth $16.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

128,034

Previous 606,834 78.9%

Holding current value

$16.4 Million

Previous $95.9 Million 83.32%

% of portfolio

0.04%

Previous 0.22%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $59.5 Million - $75.1 Million	-478,800 Reduced 78.9%	128,034 $16 Million
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $6.18 Million - $8.93 Million	-54,500 Reduced 8.24%	606,834 $95.9 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $4.2 Million - $6.34 Million	-44,800 Reduced 6.34%	661,334 $85.6 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $21.2 Million - $39.3 Million	-314,800 Reduced 30.83%	706,134 $68.1 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $24.4 Million - $29.5 Million	-238,500 Reduced 18.94%	1,020,934 $124 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $8.91 Million - $13.2 Million	83,700 Added 7.12%	1,259,434 $144 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $66.5 Million - $88.3 Million	566,100 Added 92.86%	1,175,734 $162 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $7.58 Million - $9.94 Million	75,200 Added 14.07%	609,634 $79 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $19.4 Million - $30.5 Million	256,000 Added 91.94%	534,434 $59.1 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $3.82 Million - $5.39 Million	-60,900 Reduced 17.95%	278,434 $20.9 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $7.39 Million - $10.6 Million	-117,100 Reduced 25.66%	339,334 $26.5 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $35.3 Million - $45.4 Million	456,434 New	456,434 $41.1 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $1.73 Million - $2.65 Million	-17,792 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $7.83 Million - $11 Million	-67,900 Reduced 79.24%	17,792 $2.87 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $3.5 Million - $7.51 Million	48,834 Added 132.49%	85,692 $11.3 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $1.99 Million - $3.03 Million	36,858 New	36,858 $2.73 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account